Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1T | 3.4T | 3.1T | 3.3T |
Cost of revenue | 2.8T | 3.1T | 2.9T | 3.0T |
Gross profit | 291.2B | 307.8B | 256.6B | 274.3B |
Operating expense | ||||
Research & development | — | 19.0B | 14.4B | 16.4B |
Selling general and admin | 220.8B | 62.1B | 50.5B | 56.6B |
Other operating expenses | — | 69.6B | -10.7B | -11.4B |
Operating income | 291.2B | 42.8B | 103.4B | 113.2B |
Non operating interest income | ||||
Income | — | 46.8B | 42.2B | 42.6B |
Expense | — | 78.1B | 79.9B | 77.0B |
Other income expense | — | — | — | — |
Pretax income | 42.5B | 26.0B | 181.2B | 55.5B |
Tax provision | 28.8B | 57.5B | 60.4B | 20.3B |
Net income | 13.7B | -31.5B | 120.8B | 35.2B |
Basic EPS | 334.2 | — | 1.4K | 317 |
Diluted EPS | 334.2 | — | 1.4K | 317 |
Basic average shares | — | — | 84.9M | 84.8M |
Diluted average shares | — | — | 84.9M | 84.8M |
EBITDA | 291.2B | 204.7B | 325.0B | 207.5B |
Net income from continuing op. | — | -31.5B | 120.8B | 35.2B |
Minority interests | 14.6B | -3.4B | -2.2B | -8.3B |
Preferred stock dividends | — | — | — | — |